Harvoni hepatitis C drug

Numéro d’image : 11710003
Harvoni hepatitis C drug
Harvoni hepatitis C drug. Packaging and pills for the combination drug Harvoni,used to treat chronic hepatitis C infections. It contains the drugs sofosbuvir and ledipasvir. Sofosbuvir is an antiviral drug that works by inhibiting the enzyme that the virus uses to replicate its RNA (ribonucleic acid) genome. Ledipasvir is an antiviral protease inhibitor drug that inhibits the action of a protein that is vital for RNA replication. The hepatitis C virus infects liver cells causing an inflammatory disease that can lead to degeneration and scarring (cirrhosis). Harvoni cures 90 per cent of patients. Produced by Gilead Sciences,it was first approved for use in October 2014
Licence : Droits gérés
Crédit: Science Photo Library / Post, George
Taille de l’image : 3579 px × 5368 px
Model Release : Non requis
Property Release : Non requis
Restrictions :
  • Editorial use only

Prix pour cette image À partir de 45 €

Produit vendu
(Calendrier, Carte postale, Carte de vœux, Impression sur textile, Packaging etc)
À partir de 45 €
Usage commercial
(Affichage, Annonce presse, Annonce TV, Carte, Digital - hors rés. sociaux, Digital - rés. sociaux etc)
À partir de 45 €
Éditorial
(Digital, Journal, Livre, Livre pratique, Magazine, Télévision etc)
À partir de 60 €
Usage non-commercial
(Digital - hors rés. sociaux, Digital - rés. sociaux etc)
À partir de 120 €

Mots clés

;